Ketamine Peak Plasma Concentration by Route: Timing

Ketamine reaches peak plasma concentration fastest when given intravenously, because it enters the bloodstream directly. Intramuscular and intranasal administration generally peak later, while oral and sublingual routes usually have the most variable timing because absorption occurs through the mouth or digestive system. Peak concentration, often called Tmax, is only one part of a route comparison: dose, formulation, food intake, nasal technique, and individual metabolism can all change the result.

For mental-health treatment decisions, this information is educational rather than medical advice. Generic ketamine is prescribed off-label for depression and most mental-health uses in the United States. The FDA states that esketamine, sold as Spravato, is FDA-approved for treatment-resistant depression under specified conditions.

What “peak plasma concentration” means

Plasma is the liquid part of blood. Peak plasma concentration is the highest measured amount of a medicine in plasma after a dose, and Tmax is the time needed to reach that peak. Researchers use these pharmacokinetic measurements to describe how the body absorbs, distributes, and clears a drug.

Peak blood levels do not map perfectly to a person's experience. Ketamine is rapidly distributed from blood into tissues, including the brain, and it is converted into metabolites. Learn more about ketamine metabolites norketamine hydroxynorketamine to understand why a blood-level graph is not the same as a measure of clinical effect.

According to the FDA prescribing information for Spravato, the median time to maximum esketamine concentration after intranasal administration is 20 to 40 minutes.

Why routes reach different peaks

IV administration bypasses absorption barriers, so its blood concentration rises quickly. IM ketamine must move from muscle tissue into circulation. Intranasal treatment is absorbed across nasal tissue, and some of a dose may be swallowed. Sublingual treatment is absorbed under the tongue, but swallowed medicine can add a delayed oral component. Oral ketamine travels through the gastrointestinal tract and then the liver before more of it reaches systemic circulation.

This liver processing is called first-pass metabolism. It contributes to lower and more variable systemic exposure after oral dosing than after IV dosing in published pharmacokinetic reviews, including a 2013 review in CNS Neuroscience & Therapeutics. It also changes the relative contribution of metabolites such as norketamine.

Peak timing is related to, but not identical with, the practical question of ketamine onset time by route of administration. A person may notice effects before, around, or after a measured blood peak, depending on the route and study design.

How to use this information when comparing treatment methods

A route with a fast peak may offer tighter control over timing in a monitored setting, but it can also create a more abrupt change in blood levels. A route with slower absorption may be more variable and may produce a different balance of ketamine and metabolites. Neither pattern is automatically better.

• Ask whether the timing discussed comes from ketamine, esketamine, or a specific formulation.
• Ask how the route is supervised and what monitoring occurs during and after dosing.
• Ask how your medical history, other medicines, and blood-pressure risk affect route selection.
• Separate pharmacokinetic findings from evidence about outcomes for the condition being treated.

Evidence for ketamine in depression includes studies using more than one route, with different doses and protocols. How to read ketamine depression research studies can help you identify what a study actually measured. For route-specific context, see buccal ketamine administration absorption and clinical use and subcutaneous ketamine administration clinical use.

Peak concentration is not the same as half-life

Tmax describes when the highest measured blood level occurs. Half-life describes how long it takes for the plasma concentration to fall by about half during a defined phase of elimination. These terms answer different questions, and both vary by route, dose, study method, and the chemical being measured. Read ketamine half-life by route of administration for a separate explanation of clearance timing.

In 2026, the most useful way to compare routes is to consider peak timing alongside evidence quality, supervision, safety, access, cost, and your clinician's assessment. A peak concentration chart can clarify how a route works, but it cannot choose treatment for you.